Zentek (ZTEK) Net Income towards Common Stockholders (2021 - 2026)
Zentek (ZTEK) posted quarterly Net Income towards Common Stockholders of -$2.9 million for Q1 2026, up 78.76% year-on-year from -$1.6 million in Q1 2025, and down 45.66% on a QoQ basis from -$2.0 million in Q4 2025.
Zentek (ZTEK) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends
Zentek (ZTEK) has reported Net Income towards Common Stockholders for 6 consecutive years, with -$2.9 million the latest figure, recorded in Q1 2026.
- Quarterly Net Income towards Common Stockholders rose 78.76% year-over-year to -$2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.9 million (up 34.1% YoY) and the FY2026 annual result came in at -$7.1 million, up 2.13% from the prior year.
- Net Income towards Common Stockholders retreated to -$2.9 million in Q1 2026 per ZTEK's latest filing, from -$2.0 million in the prior quarter.
- Over the last five years, Net Income towards Common Stockholders for ZTEK reached as high as $2.7 million in Q3 2023 and fell as low as -$20.9 million in Q1 2023.
- A 5-year average of -$2.4 million and a median of -$805029.4 in 2024 frame the typical range for Net Income towards Common Stockholders.
- The largest YoY upside for Net Income towards Common Stockholders was 11635669562.62% in 2023 against a maximum downside of 14225.11% in 2023.
- Year by year, Net Income towards Common Stockholders stood at $0.02 in 2022, then surged by 11635669562.62% to $2.6 million in 2023, then decreased by 28.13% to $1.8 million in 2024, then slumped by 206.86% to -$2.0 million in 2025, then sank by 45.66% to -$2.9 million in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$2.9 million, -$2.0 million, and -$1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 22.13 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 13.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Zentek | 61.38 Mn | 60.43 Mn | -979,642.64 | -2.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.88 Mn |
| Dec 31, 2025 | -1.97 Mn |
| Sep 30, 2025 | -1.74 Mn |
| Jun 30, 2025 | -1.28 Mn |
| Mar 31, 2025 | -13.54 Mn |
| Dec 31, 2024 | 1.85 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | -1.83 Mn |
| Mar 31, 2024 | -326,038.53 |
| Dec 31, 2023 | 2.57 Mn |
| Sep 30, 2023 | 2.68 Mn |
| Jun 30, 2023 | -2.39 Mn |
| Mar 31, 2023 | -20.92 Mn |
| Dec 31, 2022 | 0.02 |
| Sep 30, 2022 | 0.04 |
| Jun 30, 2022 | -16,657.04 |
| Dec 31, 2021 | 0.06 |
| Sep 30, 2021 | 0.02 |